179 related articles for article (PubMed ID: 33462347)
1. Cyrius: accurate CYP2D6 genotyping using whole-genome sequencing data.
Chen X; Shen F; Gonzaludo N; Malhotra A; Rogert C; Taft RJ; Bentley DR; Eberle MA
Pharmacogenomics J; 2021 Apr; 21(2):251-261. PubMed ID: 33462347
[TBL] [Abstract][Full Text] [Related]
2. Stargazer: a software tool for calling star alleles from next-generation sequencing data using CYP2D6 as a model.
Lee SB; Wheeler MM; Patterson K; McGee S; Dalton R; Woodahl EL; Gaedigk A; Thummel KE; Nickerson DA
Genet Med; 2019 Feb; 21(2):361-372. PubMed ID: 29875422
[TBL] [Abstract][Full Text] [Related]
3. StellarPGx: A Nextflow Pipeline for Calling Star Alleles in Cytochrome P450 Genes.
Twesigomwe D; Drögemöller BI; Wright GEB; Siddiqui A; da Rocha J; Lombard Z; Hazelhurst S
Clin Pharmacol Ther; 2021 Sep; 110(3):741-749. PubMed ID: 33492672
[TBL] [Abstract][Full Text] [Related]
4. Calling Star Alleles With Stargazer in 28 Pharmacogenes With Whole Genome Sequences.
Lee SB; Wheeler MM; Thummel KE; Nickerson DA
Clin Pharmacol Ther; 2019 Dec; 106(6):1328-1337. PubMed ID: 31206625
[TBL] [Abstract][Full Text] [Related]
5. Multiplex SNaPshot-a new simple and efficient CYP2D6 and ADRB1 genotyping method.
Ben S; Cooper-DeHoff RM; Flaten HK; Evero O; Ferrara TM; Spritz RA; Monte AA
Hum Genomics; 2016 Apr; 10():11. PubMed ID: 27108086
[TBL] [Abstract][Full Text] [Related]
6. Allele Drop Out Conferred by a Frequent CYP2D6 Genetic Variation For Commonly Used CYP2D6*3 Genotyping Assays.
Scantamburlo G; Tziolia K; Zopf M; Bernardinelli E; Soyal SM; Civello DA; Vanoni S; Dossena S; Patsch W; Patrinos GP; Paulmichl M; Nofziger C
Cell Physiol Biochem; 2017; 43(6):2297-2309. PubMed ID: 29073588
[TBL] [Abstract][Full Text] [Related]
7. Cas9 targeted nanopore sequencing with enhanced variant calling improves CYP2D6-CYP2D7 hybrid allele genotyping.
Rubben K; Tilleman L; Deserranno K; Tytgat O; Deforce D; Van Nieuwerburgh F
PLoS Genet; 2022 Sep; 18(9):e1010176. PubMed ID: 36149915
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in CYP2D6 duplication-negative individuals with the ultrarapid metabolizer phenotype: a role for the CYP2D6*35 allele in ultrarapid metabolism?
Løvlie R; Daly AK; Matre GE; Molven A; Steen VM
Pharmacogenetics; 2001 Feb; 11(1):45-55. PubMed ID: 11207030
[TBL] [Abstract][Full Text] [Related]
9. Interrogation of CYP2D6 Structural Variant Alleles Improves the Correlation Between CYP2D6 Genotype and CYP2D6-Mediated Metabolic Activity.
Dalton R; Lee SB; Claw KG; Prasad B; Phillips BR; Shen DD; Wong LH; Fade M; McDonald MG; Dunham MJ; Fowler DM; Rettie AE; Schuetz E; Thornton TA; Nickerson DA; Gaedigk A; Thummel KE; Woodahl EL
Clin Transl Sci; 2020 Jan; 13(1):147-156. PubMed ID: 31536170
[TBL] [Abstract][Full Text] [Related]
10. Nanopore sequencing of the pharmacogene
Liau Y; Maggo S; Miller AL; Pearson JF; Kennedy MA; Cree SL
Pharmacogenomics; 2019 Sep; 20(14):1033-1047. PubMed ID: 31559921
[No Abstract] [Full Text] [Related]
11. Cypiripi: exact genotyping of CYP2D6 using high-throughput sequencing data.
Numanagić I; Malikić S; Pratt VM; Skaar TC; Flockhart DA; Sahinalp SC
Bioinformatics; 2015 Jun; 31(12):i27-34. PubMed ID: 26072492
[TBL] [Abstract][Full Text] [Related]
12. Resolving discordant
Hongkaew Y; Wang WY; Gaedigk R; Sukasem C; Gaedigk A
Pharmacogenomics; 2021 Jun; 22(9):529-541. PubMed ID: 33998274
[No Abstract] [Full Text] [Related]
13. A Review of the Important Role of
Taylor C; Crosby I; Yip V; Maguire P; Pirmohamed M; Turner RM
Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33143137
[TBL] [Abstract][Full Text] [Related]
14. Phenotype prediction and characterization of 25 pharmacogenes in Thais from whole genome sequencing for clinical implementation.
Mauleekoonphairoj J; Chamnanphon M; Khongphatthanayothin A; Sutjaporn B; Wandee P; Poovorawan Y; Nademanee K; Pongpanich M; Chariyavilaskul P
Sci Rep; 2020 Nov; 10(1):18969. PubMed ID: 33144648
[TBL] [Abstract][Full Text] [Related]
15. Accurate determination of the CYP2D6 (*1/*4)xN genotype by quantitative PCR.
Pondman KM; van Schaik RHN; van der Weide J
Drug Metab Pers Ther; 2018 Mar; 33(1):33-39. PubMed ID: 29420304
[TBL] [Abstract][Full Text] [Related]
16. Identification of CYP2D6 Haplotypes that Interfere with Commonly Used Assays for Copy Number Variation Characterization.
Turner AJ; Aggarwal P; Boone EC; Haidar CE; Relling MV; Derezinski AD; Broeckel U; Gaedigk A
J Mol Diagn; 2021 May; 23(5):577-588. PubMed ID: 33631352
[TBL] [Abstract][Full Text] [Related]
17. CYP2D6: novel genomic structures and alleles.
Kramer WE; Walker DL; O'Kane DJ; Mrazek DA; Fisher PK; Dukek BA; Bruflat JK; Black JL
Pharmacogenet Genomics; 2009 Oct; 19(10):813-22. PubMed ID: 19741566
[TBL] [Abstract][Full Text] [Related]
18. CYP2D6 haplotypes with enhancer single-nucleotide polymorphism rs5758550 and rs16947 (*2 allele): implications for CYP2D6 genotyping panels.
Ray B; Ozcagli E; Sadee W; Wang D
Pharmacogenet Genomics; 2019 Feb; 29(2):39-47. PubMed ID: 30520769
[TBL] [Abstract][Full Text] [Related]
19. Analytical Validation of a Computational Method for Pharmacogenetic Genotyping from Clinical Whole Exome Sequencing.
Ly RC; Shugg T; Ratcliff R; Osei W; Lynnes TC; Pratt VM; Schneider BP; Radovich M; Bray SM; Salisbury BA; Parikh B; Sahinalp SC; Numanagić I; Skaar TC
J Mol Diagn; 2022 Jun; 24(6):576-585. PubMed ID: 35452844
[TBL] [Abstract][Full Text] [Related]
20. Sequencing the CYP2D6 gene: from variant allele discovery to clinical pharmacogenetic testing.
Yang Y; Botton MR; Scott ER; Scott SA
Pharmacogenomics; 2017 May; 18(7):673-685. PubMed ID: 28470112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
